Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 11 years
- Director since
- 2023
11 years of board service in total across 3 boards, counting each seat separately. Longest: Vir Biotechnology Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Agilent Technologies Inc. March 18, 202687.3%
-
Voyager Therapeutics Inc. June 3, 202583.2%
-
Agilent Technologies Inc. March 15, 202385.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 19, 2026 | Agilent Technologies Inc. | Grant or award | +2,158 | $111.75 | $241,157 |
| Mar 19, 2026 | Agilent Technologies Inc. | Grant or award | +1,057 | $111.75 | $118,120 |
| Mar 14, 2025 | Agilent Technologies Inc. | Grant or award | +1,819 | $121.18 | $220,426 |
| Feb 24, 2025 | Vir Biotechnology Inc. | Open-market sale | −10,056 | $9.45 | $95,029 |
| Feb 18, 2025 | Vir Biotechnology Inc. | Open-market sale | −10,964 | $9.81 | $107,557 |
| Oct 23, 2024 | Vir Biotechnology Inc. | Other | +598,270 | — | — |
| Oct 23, 2024 | Vir Biotechnology Inc. | Other | −598,270 | — | — |
| Oct 23, 2024 | Vir Biotechnology Inc. | Other | +598,270 | — | — |
| Oct 23, 2024 | Vir Biotechnology Inc. | Other | −598,270 | — | — |
| May 30, 2024 | Vir Biotechnology Inc. | Grant or award | +8,000 | — | — |
| May 29, 2024 | Agilent Technologies Inc. | Gift | −3,443 | $145.48 | $500,888 |
| May 29, 2024 | Agilent Technologies Inc. | Gift | +3,443 | $145.48 | $500,888 |
| Mar 15, 2024 | Agilent Technologies Inc. | Grant or award | +1,678 | $147.48 | $247,471 |
| Feb 26, 2024 | Vir Biotechnology Inc. | Open-market sale | −17,722 | $11.65 | $206,461 |
| Feb 22, 2024 | Vir Biotechnology Inc. | Open-market sale | −10,028 | $10.05 | $100,781 |
Questions about George A. Scangos
What boards is George A. Scangos on?
George A. Scangos sits on the boards of Agilent Technologies Inc., Vir Biotechnology Inc. and Voyager Therapeutics Inc.
What company is George A. Scangos the CEO of?
George A. Scangos has been President and CEO of Vir Biotechnology Inc. since January 2017.
How long has George A. Scangos served on boards?
Our records show at least 11 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.